Physician

Paul J Botelho, MD

According to 2025 Medicare claims, Paul Botelho, MD (NPI: 1982694006) practices ophthalmology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Bristol, MA. This provider's primary affiliated billing organization is ADVANCED EYE CENTERS INC (NPI: 1740231323; TIN: 450498351) and primary practice location at 02747-1279. Botelho is affiliated with the Southcoast Accountable Care Organization, LLC (ACO ID: A1522), participating under the MSSP model.

Botelho's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,926 traditional Medicare patients, billed 5,858 HCPCS/CPT codes, and received $474,051 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 5,697 prescription claims across 1,225 beneficiaries totaling $599,224 in drug costs, led by Restasis (Cyclosporine). DME data shows 69 claims. Open Payments data shows 7 records totaling $200. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $280,006 to $474,051. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $228,643 to $599,224. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,018	2,802	$280,006
2016	1,119	3,005	$305,233
2017	1,314	4,232	$370,139
2018	1,570	4,501	$482,089
2019	1,834	5,611	$502,874
2020	1,737	4,583	$360,920
2021	2,048	6,038	$501,068
2022	1,887	6,254	$425,796
2023	1,835	6,502	$441,087
2024	1,926	5,858	$474,051

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	454	2,680	$228,643
2016	525	3,227	$279,324
2017	641	3,590	$336,616
2018	809	4,312	$375,795
2019	936	4,468	$406,594
2020	973	5,187	$573,798
2021	1,125	5,149	$614,566
2022	1,079	4,695	$682,455
2023	1,126	5,274	$710,898
2024	1,225	5,697	$599,224

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	59	59	$4,094
2016	43	44	$2,127
2017	81	83	$4,232
2018	158	158	$8,661
2019	69	69	$3,426
2020	25	25	$1,207
2021	99	99	$5,488
2022	57	57	$2,892
2023	75	76	$4,165
2024	69	69	$4,616

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	1,401	1,526	$91
92012	Established patient problem focused exam of visual system	502	807	$71
92083	Exam of visual field with extended testing	319	322	$47
92136	Measurement of corneal curvature and depth of eye	371	371	$31
92133	Imaging of optic nerve	308	312	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	132	8,625	$174,877
Lumigan	Bimatoprost	223	12,456	$115,108
Xiidra	Lifitegrast	43	2,310	$51,029
Prednisolone Acetate	Prednisolone Acetate	800	34,794	$41,160
Rhopressa	Netarsudil Mesylate	50	2,267	$26,417

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2304	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 2.25-4.00d cylinder, per lens	N	21	21	$2,548
V2020	Frames, purchases	N	26	26	$1,611
V2755	U-v lens, per lens	N	22	22	$457

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$200	BIOTISSUE HOLDINGS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul J. Botelho, MD?

Tedicare shows public-source Medicare data for Paul J. Botelho, MD (NPI 1982694006), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul J. Botelho, MD have ACO affiliation data?

Paul J. Botelho, MD is shown with ACO affiliation data for Southcoast Accountable Care Organization, LLC (MSSP, ACO ID A1522).

What billing organization is linked to Paul J. Botelho, MD?

Paul J. Botelho, MD is linked to ADVANCED EYE CENTERS INC (billing NPI 1740231323) in the available physician profile data.

Does Paul J. Botelho, MD have Open Payments data?

Paul J. Botelho, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.